Key Points
- Director sale: DocuSign director Anna Marrs sold 363 shares on March 5 at an average price of $46.33 for $16,817.79, trimming her stake to 12,251 shares (a 2.88% reduction); she previously sold 363 shares on Dec. 5 at $64.50.
- Market and analyst context: DOCU traded down to $47.52 (about -1.5%) with a market cap near $9.5B, and Wall Street's consensus rating is a "Hold" with an average price target of $78.80 (five Buys, sixteen Holds).
Docusign Inc. (NASDAQ:DOCU - Get Free Report) Director Anna Marrs sold 363 shares of the company's stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $46.33, for a total transaction of $16,817.79. Following the completion of the sale, the director directly owned 12,251 shares in the company, valued at $567,588.83. This trade represents a 2.88% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Anna Marrs also recently made the following trade(s):
- On Friday, December 5th, Anna Marrs sold 363 shares of Docusign stock. The shares were sold at an average price of $64.50, for a total transaction of $23,413.50.
Docusign Trading Down 1.5%
DOCU traded down $0.71 during midday trading on Friday, hitting $47.52. 1,186,342 shares of the company were exchanged, compared to its average volume of 4,833,926. The company's 50 day simple moving average is $54.26 and its 200 day simple moving average is $66.00. The firm has a market capitalization of $9.52 billion, a price-to-earnings ratio of 33.23, a price-to-earnings-growth ratio of 2.01 and a beta of 1.03. Docusign Inc. has a 1-year low of $40.16 and a 1-year high of $94.67.
Wall Street Analyst Weigh In
Several equities research analysts have commented on DOCU shares. HSBC set a $53.00 price objective on Docusign in a research report on Friday, February 13th. Zacks Research downgraded shares of Docusign from a "strong-buy" rating to a "hold" rating in a report on Monday, November 24th. UBS Group dropped their price target on shares of Docusign from $85.00 to $75.00 and set a "neutral" rating on the stock in a research report on Friday, December 5th. Evercore decreased their price objective on shares of Docusign from $92.00 to $80.00 and set an "in-line" rating for the company in a research report on Friday, December 5th. Finally, Cantor Fitzgerald restated an "outperform" rating on shares of Docusign in a research report on Wednesday, December 17th. Five analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $78.80.
Read Our Latest Stock Report on DOCU
Institutional Trading of Docusign
A number of institutional investors and hedge funds have recently modified their holdings of the stock. NewEdge Advisors LLC lifted its position in shares of Docusign by 36.4% in the first quarter. NewEdge Advisors LLC now owns 9,202 shares of the company's stock valued at $749,000 after acquiring an additional 2,457 shares in the last quarter. AlphaQuest LLC acquired a new stake in Docusign during the 2nd quarter worth $129,000. Envestnet Asset Management Inc. grew its holdings in shares of Docusign by 58.8% during the second quarter. Envestnet Asset Management Inc. now owns 281,525 shares of the company's stock worth $21,928,000 after buying an additional 104,293 shares in the last quarter. Hantz Financial Services Inc. raised its position in shares of Docusign by 106.3% in the second quarter. Hantz Financial Services Inc. now owns 848 shares of the company's stock valued at $66,000 after buying an additional 437 shares during the last quarter. Finally, Atria Investments Inc lifted its stake in shares of Docusign by 5.6% in the second quarter. Atria Investments Inc now owns 8,455 shares of the company's stock worth $659,000 after buying an additional 449 shares in the last quarter. Hedge funds and other institutional investors own 77.64% of the company's stock.
About Docusign
(
Get Free Report)
DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company's flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign's Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.
DocuSign's platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
